Selected article for: "antigen presentation and HLA regulation"

Author: Menachery, Vineet D.; Schäfer, Alexandra; Burnum-Johnson, Kristin E.; Mitchell, Hugh D.; Eisfeld, Amie J.; Walters, Kevin B.; Nicora, Carrie D.; Purvine, Samuel O.; Casey, Cameron P.; Monroe, Matthew E.; Weitz, Karl K.; Stratton, Kelly G.; Webb-Robertson, Bobbie-Jo M.; Gralinski, Lisa E.; Metz, Thomas O.; Smith, Richard D.; Waters, Katrina M.; Sims, Amy C.; Kawaoka, Yoshihiro; Baric, Ralph S.
Title: MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape
  • Document date: 2018_1_30
  • ID: 096gtdy5_20
    Snippet: CoV infection suggested that a nonconserved portion of the MERS-CoV backbone is involved. With this in mind, we focused on the MERS-CoV accessory ORF proteins, which have limited sequence similarities with other CoV family proteins. Using a previously described MERS-CoV mutant that deletes all four accessory ORFs (d3-5) (15), we infected Calu3 cells and examined both viral replication and proteomics. Following infection, the d3-5 mutant virus pro.....
    Document: CoV infection suggested that a nonconserved portion of the MERS-CoV backbone is involved. With this in mind, we focused on the MERS-CoV accessory ORF proteins, which have limited sequence similarities with other CoV family proteins. Using a previously described MERS-CoV mutant that deletes all four accessory ORFs (d3-5) (15), we infected Calu3 cells and examined both viral replication and proteomics. Following infection, the d3-5 mutant virus produced robust attenuation in terms of viral replication (Fig. S3B) . However, despite a nearly 100-fold reduction in viral replication, the d3-5 mutant viruses maintained strong down-regulation of MHC class I molecules HLA-A and -C ( Fig. 6 C and D) . While not equivalent to WT MERS-CoV down-regulation, the d3-5 mutant maintained lower absolute MHC class I peptide abundance compared with WT H5N1-VN1203 ( Fig. 6 A and B) . Together, the data suggest that even a robustly attenuated MERS-CoV mutant can stimulate down-regulation of antigen-presentation molecules and potentially implicate host processes in contributing to reduction of MHC class I molecules following infection.

    Search related documents:
    Co phrase search for related documents
    • abundance peptide and CoV infection: 1, 2
    • abundance peptide and MERS cov: 1
    • accessory orf and antigen presentation: 1, 2, 3
    • accessory orf and CoV infection: 1, 2, 3, 4, 5, 6, 7
    • accessory orf and MERS cov: 1, 2, 3, 4, 5
    • accessory ORF protein and CoV infection: 1, 2
    • accessory ORF protein and MERS cov: 1
    • antigen presentation and CoV family: 1, 2
    • antigen presentation and CoV infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antigen presentation and HLA molecule: 1, 2
    • antigen presentation and host process: 1
    • antigen presentation and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antigen presentation molecule and CoV infection: 1
    • antigen presentation molecule and MERS cov: 1
    • CoV family and HLA molecule: 1
    • CoV family and host process: 1, 2
    • CoV family and infection follow: 1, 2, 3
    • CoV family and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • CoV infection and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25